LRBA regulates the availability of CTLA4, autophagy, and cell metabolism
In 2012 we identified LRBA as being mutated in patients with autosomal recessive immune dysregulation and immunodeficiency (Lopez-Herrera et al., Am J Hum Genet, 2012). Following this discovery, we found that LRBA regulates autophagy. Others (Lo et al.; Science, 2015) identified LRBA as a key regulator of CTLA-4 trafficking. This project now evaluates the role of LRBA in cancer, its role in cell metabolism, and how we can use this knowledge for human diseases. This project is funded by the Wilhelm Sander-Stiftung, Förderantrags-Nr.2023.115.1.
References
Contact
Dr. Hannah van Dijk
E-Mail